Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global NGS-based RNA-seq Market Size, Status and Forecast 2020-2026

  • BMR3958458
  • 95 Pages
  • July 2020
  • Medical Devices
Download Sample    Get Discount   
 
Factors such as the advantages of RNA-seq over microarray technology, technological advancements in RNA-seq products, increasing number of RNA-seq grants, increasing number of research activities, and rapid growth in precision medicine are driving the growth of the NGS-based RNA-seq market.

The hospitals and clinics segment is expected to register the highest growth due to the growing number of agreements between companies and hospitals for the development of advanced tests and products catering to the specific needs of hospitals and clinics.

Market Analysis and Insights: Global NGS-based RNA-seq Market

The global NGS-based RNA-seq market size is projected to reach US$ 1581.9 million by 2026, from US$ 1409.2 million in 2020, at a CAGR of 11.3%% during 2021-2026.

Global NGS-based RNA-seq Scope and Market Size

NGS-based RNA-seq market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NGS-based RNA-seq market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The following players are covered in this report:

Illumina

Thermo Fisher Scientific

Pacific Biosciences Of California

Qaigen

F. Hoffmann-La Roche

Agilent Technologies

Oxford Nanopore Technologies

Perkinelmer

Eurofins Scientific

Gatc Biotech

Macrogen

NGS-based RNA-seq Breakdown Data by Type

SBS

SMRT

NGS-based RNA-seq Breakdown Data by Application

Transcriptome Epigenetics

Small RNA

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by NGS-based RNA-seq Revenue

1.4 Market by Type

1.4.1 Global NGS-based RNA-seq Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 SBS

1.4.3 SMRT

1.5 Market by Application

1.5.1 Global NGS-based RNA-seq Market Share by Application: 2020 VS 2026

1.5.2 Transcriptome Epigenetics

1.5.3 Small RNA

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global NGS-based RNA-seq Market Perspective (2015-2026)

2.2 Global NGS-based RNA-seq Growth Trends by Regions

2.2.1 NGS-based RNA-seq Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 NGS-based RNA-seq Historic Market Share by Regions (2015-2020)

2.2.3 NGS-based RNA-seq Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 NGS-based RNA-seq Market Growth Strategy

2.3.6 Primary Interviews with Key NGS-based RNA-seq Players (Opinion Leaders)

3 Competition Landscape by Key Players

3.1 Global Top NGS-based RNA-seq Players by Market Size

3.1.1 Global Top NGS-based RNA-seq Players by Revenue (2015-2020)

3.1.2 Global NGS-based RNA-seq Revenue Market Share by Players (2015-2020)

3.1.3 Global NGS-based RNA-seq Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global NGS-based RNA-seq Market Concentration Ratio

3.2.1 Global NGS-based RNA-seq Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by NGS-based RNA-seq Revenue in 2019

3.3 NGS-based RNA-seq Key Players Head office and Area Served

3.4 Key Players NGS-based RNA-seq Product Solution and Service

3.5 Date of Enter into NGS-based RNA-seq Market

3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

4.1 Global NGS-based RNA-seq Historic Market Size by Type (2015-2020)

4.2 Global NGS-based RNA-seq Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

5.1 Global NGS-based RNA-seq Market Size by Application (2015-2020)

5.2 Global NGS-based RNA-seq Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America NGS-based RNA-seq Market Size (2015-2020)

6.2 NGS-based RNA-seq Key Players in North America (2019-2020)

6.3 North America NGS-based RNA-seq Market Size by Type (2015-2020)

6.4 North America NGS-based RNA-seq Market Size by Application (2015-2020)

7 Europe

7.1 Europe NGS-based RNA-seq Market Size (2015-2020)

7.2 NGS-based RNA-seq Key Players in Europe (2019-2020)

7.3 Europe NGS-based RNA-seq Market Size by Type (2015-2020)

7.4 Europe NGS-based RNA-seq Market Size by Application (2015-2020)

8 China

8.1 China NGS-based RNA-seq Market Size (2015-2020)

8.2 NGS-based RNA-seq Key Players in China (2019-2020)

8.3 China NGS-based RNA-seq Market Size by Type (2015-2020)

8.4 China NGS-based RNA-seq Market Size by Application (2015-2020)

9 Japan

9.1 Japan NGS-based RNA-seq Market Size (2015-2020)

9.2 NGS-based RNA-seq Key Players in Japan (2019-2020)

9.3 Japan NGS-based RNA-seq Market Size by Type (2015-2020)

9.4 Japan NGS-based RNA-seq Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia NGS-based RNA-seq Market Size (2015-2020)

10.2 NGS-based RNA-seq Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia NGS-based RNA-seq Market Size by Type (2015-2020)

10.4 Southeast Asia NGS-based RNA-seq Market Size by Application (2015-2020)

11 India

11.1 India NGS-based RNA-seq Market Size (2015-2020)

11.2 NGS-based RNA-seq Key Players in India (2019-2020)

11.3 India NGS-based RNA-seq Market Size by Type (2015-2020)

11.4 India NGS-based RNA-seq Market Size by Application (2015-2020)

12 Central & South America

12.1 Central & South America NGS-based RNA-seq Market Size (2015-2020)

12.2 NGS-based RNA-seq Key Players in Central & South America (2019-2020)

12.3 Central & South America NGS-based RNA-seq Market Size by Type (2015-2020)

12.4 Central & South America NGS-based RNA-seq Market Size by Application (2015-2020)

13 Key Players Profiles

13.1 Illumina

13.1.1 Illumina Company Details

13.1.2 Illumina Business Overview

13.1.3 Illumina NGS-based RNA-seq Introduction

13.1.4 Illumina Revenue in NGS-based RNA-seq Business (2015-2020))

13.1.5 Illumina Recent Development

13.2 Thermo Fisher Scientific

13.2.1 Thermo Fisher Scientific Company Details

13.2.2 Thermo Fisher Scientific Business Overview

13.2.3 Thermo Fisher Scientific NGS-based RNA-seq Introduction

13.2.4 Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2015-2020)

13.2.5 Thermo Fisher Scientific Recent Development

13.3 Pacific Biosciences Of California

13.3.1 Pacific Biosciences Of California Company Details

13.3.2 Pacific Biosciences Of California Business Overview

13.3.3 Pacific Biosciences Of California NGS-based RNA-seq Introduction

13.3.4 Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2015-2020)

13.3.5 Pacific Biosciences Of California Recent Development

13.4 Qaigen

13.4.1 Qaigen Company Details

13.4.2 Qaigen Business Overview

13.4.3 Qaigen NGS-based RNA-seq Introduction

13.4.4 Qaigen Revenue in NGS-based RNA-seq Business (2015-2020)

13.4.5 Qaigen Recent Development

13.5 F. Hoffmann-La Roche

13.5.1 F. Hoffmann-La Roche Company Details

13.5.2 F. Hoffmann-La Roche Business Overview

13.5.3 F. Hoffmann-La Roche NGS-based RNA-seq Introduction

13.5.4 F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2015-2020)

13.5.5 F. Hoffmann-La Roche Recent Development

13.6 Agilent Technologies

13.6.1 Agilent Technologies Company Details

13.6.2 Agilent Technologies Business Overview

13.6.3 Agilent Technologies NGS-based RNA-seq Introduction

13.6.4 Agilent Technologies Revenue in NGS-based RNA-seq Business (2015-2020)

13.6.5 Agilent Technologies Recent Development

13.7 Oxford Nanopore Technologies

13.7.1 Oxford Nanopore Technologies Company Details

13.7.2 Oxford Nanopore Technologies Business Overview

13.7.3 Oxford Nanopore Technologies NGS-based RNA-seq Introduction

13.7.4 Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2015-2020)

13.7.5 Oxford Nanopore Technologies Recent Development

13.8 Perkinelmer

13.8.1 Perkinelmer Company Details

13.8.2 Perkinelmer Business Overview

13.8.3 Perkinelmer NGS-based RNA-seq Introduction

13.8.4 Perkinelmer Revenue in NGS-based RNA-seq Business (2015-2020)

13.8.5 Perkinelmer Recent Development

13.9 Eurofins Scientific

13.9.1 Eurofins Scientific Company Details

13.9.2 Eurofins Scientific Business Overview

13.9.3 Eurofins Scientific NGS-based RNA-seq Introduction

13.9.4 Eurofins Scientific Revenue in NGS-based RNA-seq Business (2015-2020)

13.9.5 Eurofins Scientific Recent Development

13.10 Gatc Biotech

13.10.1 Gatc Biotech Company Details

13.10.2 Gatc Biotech Business Overview

13.10.3 Gatc Biotech NGS-based RNA-seq Introduction

13.10.4 Gatc Biotech Revenue in NGS-based RNA-seq Business (2015-2020)

13.10.5 Gatc Biotech Recent Development

13.11 Macrogen

10.11.1 Macrogen Company Details

10.11.2 Macrogen Business Overview

10.11.3 Macrogen NGS-based RNA-seq Introduction

10.11.4 Macrogen Revenue in NGS-based RNA-seq Business (2015-2020)

10.11.5 Macrogen Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

List of Tables

Table 1. NGS-based RNA-seq Key Market Segments

Table 2. Key Players Covered: Ranking by NGS-based RNA-seq Revenue

Table 3. Ranking of Global Top NGS-based RNA-seq Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global NGS-based RNA-seq Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of SBS

Table 6. Key Players of SMRT

Table 7. Global NGS-based RNA-seq Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global NGS-based RNA-seq Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global NGS-based RNA-seq Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global NGS-based RNA-seq Market Share by Regions (2015-2020)

Table 11. Global NGS-based RNA-seq Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global NGS-based RNA-seq Market Share by Regions (2021-2026)

Table 13. Market Top Trends

Table 14. Key Drivers: Impact Analysis

Table 15. Key Challenges

Table 16. NGS-based RNA-seq Market Growth Strategy

Table 17. Main Points Interviewed from Key NGS-based RNA-seq Players

Table 18. Global NGS-based RNA-seq Revenue by Players (2015-2020) (Million US$)

Table 19. Global NGS-based RNA-seq Market Share by Players (2015-2020)

Table 20. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS-based RNA-seq as of 2019)

Table 21. Global NGS-based RNA-seq by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players NGS-based RNA-seq Product Solution and Service

Table 24. Date of Enter into NGS-based RNA-seq Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 27. Global NGS-based RNA-seq Market Size Share by Type (2015-2020)

Table 28. Global NGS-based RNA-seq Revenue Market Share by Type (2021-2026)

Table 29. Global NGS-based RNA-seq Market Size Share by Application (2015-2020)

Table 30. Global NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 31. Global NGS-based RNA-seq Market Size Share by Application (2021-2026)

Table 32. North America Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 33. North America Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 34. North America NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 35. North America NGS-based RNA-seq Market Share by Type (2015-2020)

Table 36. North America NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 37. North America NGS-based RNA-seq Market Share by Application (2015-2020)

Table 38. Europe Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 39. Europe Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 40. Europe NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 41. Europe NGS-based RNA-seq Market Share by Type (2015-2020)

Table 42. Europe NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 43. Europe NGS-based RNA-seq Market Share by Application (2015-2020)

Table 44. China Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 45. China Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 46. China NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 47. China NGS-based RNA-seq Market Share by Type (2015-2020)

Table 48. China NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 49. China NGS-based RNA-seq Market Share by Application (2015-2020)

Table 50. Japan Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 51. Japan Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 52. Japan NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 53. Japan NGS-based RNA-seq Market Share by Type (2015-2020)

Table 54. Japan NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 55. Japan NGS-based RNA-seq Market Share by Application (2015-2020)

Table 56. Southeast Asia Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 57. Southeast Asia Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 58. Southeast Asia NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 59. Southeast Asia NGS-based RNA-seq Market Share by Type (2015-2020)

Table 60. Southeast Asia NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 61. Southeast Asia NGS-based RNA-seq Market Share by Application (2015-2020)

Table 62. India Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 63. India Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 64. India NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 65. India NGS-based RNA-seq Market Share by Type (2015-2020)

Table 66. India NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 67. India NGS-based RNA-seq Market Share by Application (2015-2020)

Table 68. Central & South America Key Players NGS-based RNA-seq Revenue (2019-2020) (Million US$)

Table 69. Central & South America Key Players NGS-based RNA-seq Market Share (2019-2020)

Table 70. Central & South America NGS-based RNA-seq Market Size by Type (2015-2020) (Million US$)

Table 71. Central & South America NGS-based RNA-seq Market Share by Type (2015-2020)

Table 72. Central & South America NGS-based RNA-seq Market Size by Application (2015-2020) (Million US$)

Table 73. Central & South America NGS-based RNA-seq Market Share by Application (2015-2020)

Table 74. Illumina Company Details

Table 75. Illumina Business Overview

Table 76. Illumina Product

Table 77. Illumina Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 78. Illumina Recent Development

Table 79. Thermo Fisher Scientific Company Details

Table 80. Thermo Fisher Scientific Business Overview

Table 81. Thermo Fisher Scientific Product

Table 82. Thermo Fisher Scientific Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 83. Thermo Fisher Scientific Recent Development

Table 84. Pacific Biosciences Of California Company Details

Table 85. Pacific Biosciences Of California Business Overview

Table 86. Pacific Biosciences Of California Product

Table 87. Pacific Biosciences Of California Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 88. Pacific Biosciences Of California Recent Development

Table 89. Qaigen Company Details

Table 90. Qaigen Business Overview

Table 91. Qaigen Product

Table 92. Qaigen Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 93. Qaigen Recent Development

Table 94. F. Hoffmann-La Roche Company Details

Table 95. F. Hoffmann-La Roche Business Overview

Table 96. F. Hoffmann-La Roche Product

Table 97. F. Hoffmann-La Roche Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 98. F. Hoffmann-La Roche Recent Development

Table 99. Agilent Technologies Company Details

Table 100. Agilent Technologies Business Overview

Table 101. Agilent Technologies Product

Table 102. Agilent Technologies Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 103. Agilent Technologies Recent Development

Table 104. Oxford Nanopore Technologies Company Details

Table 105. Oxford Nanopore Technologies Business Overview

Table 106. Oxford Nanopore Technologies Product

Table 107. Oxford Nanopore Technologies Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 108. Oxford Nanopore Technologies Recent Development

Table 109. Perkinelmer Business Overview

Table 110. Perkinelmer Product

Table 111. Perkinelmer Company Details

Table 112. Perkinelmer Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 113. Perkinelmer Recent Development

Table 114. Eurofins Scientific Company Details

Table 115. Eurofins Scientific Business Overview

Table 116. Eurofins Scientific Product

Table 117. Eurofins Scientific Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 118. Eurofins Scientific Recent Development

Table 119. Gatc Biotech Company Details

Table 120. Gatc Biotech Business Overview

Table 121. Gatc Biotech Product

Table 122. Gatc Biotech Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 123. Gatc Biotech Recent Development

Table 124. Macrogen Company Details

Table 125. Macrogen Business Overview

Table 126. Macrogen Product

Table 127. Macrogen Revenue in NGS-based RNA-seq Business (2015-2020) (Million US$)

Table 128. Macrogen Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global NGS-based RNA-seq Market Share by Type: 2020 VS 2026

Figure 2. SBS Features

Figure 3. SMRT Features

Figure 4. Global NGS-based RNA-seq Market Share by Application: 2020 VS 2026

Figure 5. Transcriptome Epigenetics Case Studies

Figure 6. Small RNA Case Studies

Figure 7. NGS-based RNA-seq Report Years Considered

Figure 8. Global NGS-based RNA-seq Market Size YoY Growth 2015-2026 (US$ Million)

Figure 9. Global NGS-based RNA-seq Market Share by Regions: 2020 VS 2026

Figure 10. Global NGS-based RNA-seq Market Share by Regions (2021-2026)

Figure 11. Porter's Five Forces Analysis

Figure 12. Global NGS-based RNA-seq Market Share by Players in 2019

Figure 13. Global Top NGS-based RNA-seq Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS-based RNA-seq as of 2019

Figure 14. The Top 10 and 5 Players Market Share by NGS-based RNA-seq Revenue in 2019

Figure 15. North America NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 16. Europe NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 17. China NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 18. Japan NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 19. Southeast Asia NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 20. India NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 21. Central & South America NGS-based RNA-seq Market Size YoY Growth (2015-2020) (Million US$)

Figure 22. Bottom-up and Top-down Approaches for This Report

Figure 23. Data Triangulation

Figure 24. Key Executives Interviewed

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450